Aims and Scope

The Journal of Inflammation Research is an international, peer-reviewed, open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation.

Specific topics covered by the journal include:

• acute/chronic inflammation
• mediators of inflammation
• cellular processes
• molecular mechanisms
• neuroimmune mechanisms
• pharmacology and novel anti-inflammatory drugs
• clinical conditions involving inflammation

The journal welcomes the following article types on all aspects of inflammation unless otherwise stated below.

The journal does not consider case reports except in circumstances where they make a valuable contribution to the literature. Protocols of prospective studies need to be accompanied by detailed and original video demonstrations of the proposed research. Bibliometric studies are welcome but must add significantly to the body of knowledge about inflammation research, and meta-analyses are not considered for publication.

When considering submission of a paper utilizing publicly available data (e.g. SEER/GWAS/TCGA/GEO/Vigibase etc.), authors should ensure that such studies add significantly to the body of knowledge about a specific disease or relevant phenotype and that they are validated using the authors’ own data through replication in an independent sample set and functional follow-up. Bioinformatics studies should also conform to these criteria.

The journal welcomes submissions to the following sections:

• Autoimmunity and Inflammation
• Cardiovascular Inflammation
• Dermatological Inflammation
• Diabetes and Inflammation
• Gastrointestinal Inflammation
• Liver and Gall Bladder Inflammation
• Musculoskeletal Inflammation
• Neuroinflammation
• Onco-inflammation
• Respiratory Inflammation
• Sepsis and Systemic Inflammation
• Urinary and Kidney Inflammation

 

For the following subject areas, please consider submitting to the related titles indicated:

Infectious Diseases – including enteric infections and pneumonia, tuberculosis and respiratory syncytial virus (RSV) which focuses on prevalence or general clinical prognosis - Infection and Drug Resistance. IDR publishes open access research on anti-infectives, epidemiology, vaccine development and the pathogenesis, etiology and diagnosis of infectious disease.

Hematology - excluding sepsis - Hematology. Hematology publishes open access research on hematology with interdisciplinary approaches including epidemiology, oncology, pathology, biology, clinical cancer research and management.

Women's Health -including endometriosis, mastitis, PCOS, gestational diabetes, pregnancy and maternal health - International Journal of Women’s Health or Journal of Obstetrics and Gynaecology. IJWH publishes open access research on women’s healthcare, focusing on obstetrics and gynecology, sexual and reproductive health, and psychosocial conditions. JOG publishes open access research on obstetrics and gynecology, covering maternal health, risk factors, diseases, treatment and mortality in clinical practice.

Dental Inflammation including periodontitis and pulpitis - Clinical, Cosmetic and Investigational Dentistry or Journal of Oral Microbiology. CCID publishes open access research on dentistry, focusing on cosmetic intervention, including novel materials, techniques and devices, surgery, and orthodontics. JOM publishes open access research on aetiological agents behind oral infectious diseases, including their pathogenesis, virulence, host-parasite interactions, and immunology.

Ocular Inflammation – including uveitis, glaucoma, retinitis, and retinopathy (including diabetic retinopathy) - Ocular Immunology and Inflammation or Clinical Ophthalmology. OII publishes open select research on the diagnosis and treatment of ocular, corneal and retinal inflammation, uveitis, ophthalmology, ocular immunology and vision science.

Non-inflammatory-focussed oncology submissions should be directed to related titles Cancer Management and Research and OncoTargets and Therapy.

Updated 8 July 2025